GT Biopharma Inc.

NASDAQ: GTBP
Share price (12/20/24): $1.75
Market cap (12/20/24): $3.899 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement

Initial registration of new securities – amended

Initial registration of new securities

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Urban Alan Louis

Cytovance Biologics Inc

Urban Alan Louis

Bristol Investment Fund Ltd

Armistice Capital, LLC

News Filter

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Material Definitive Agreement, Financial Statements or Exhibits

Change in Directors, Officers or Compensation

Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia

Shareholder Vote Results

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Notice of effectiveness